Mdma molecule:

Image from PubChem

Mdma Clinical Trials


A Phase 1 study to evaluate Safety, Tolerability and Pharmacokinetics of Ultramicronized-Palmitoylethanolamide (PEA) in Healthy Subjects.


To see complete record on anzctr.org.au, please visit this link

Id: ACTRN12620000213943p

Organisation Name: FSD Pharma Inc.

Overal Status: Not yet recruiting

Start Date: 07/04/2020

Brief Summary: This study of ultramicronized PEA (particle size between 0.6 and 10 µm) will investigate the safety, tolerability, PK of single and multiple ascending doses of ultramicronized PEA compared to placebo in healthy subjects.
The effect of food on the absorption of the ultramicronized PEA will also be assessed..

Countries:
  • Australia
  • Canada
Conditions:
  • Chronic Pain
  • Inflammation


Total execution time in seconds: 0.087990045547485